Back
Freeport-McMoRan Vs. Janux Therapeutics Industry Stock Comparison
Buy
54
FCX
Freeport-McMoRan
Last Price:
52.03
Seasonality Move:
2.09%
Sell
37
JANX
Janux Therapeutics
Last Price:
47.49
Seasonality Move:
8.69%
Buy
54
Freeport-McMoRan (FCX)
is a Buy
Is Freeport-McMoRan a Buy, Sell or Hold?
- The current Freeport-McMoRan [FCX] share price is $52.04. The Score for FCX is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- FCX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
37
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy, Sell or Hold?
- The current Janux Therapeutics [JANX] share price is $47.51. The Score for JANX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- JANX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FCX Stock Price Chart
What is Freeport-McMoRan's stock price today?
-
The Freeport-McMoRan share price today is $52.04
The current trend is moderately bullish and FCX is experiencing selling pressure, which indicates risk of future bearish movement.
JANX Stock Price Chart
What is Janux Therapeutics's stock price today?
-
The Janux Therapeutics share price today is $47.51
The current trend is moderately bearish and JANX is experiencing slight buying pressure.
FCX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.26 | Buy |
| Relative Strength Index (14 RSI): | 57.6 | Buy |
| Chaikin Money Flow: | -12891983 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49 - 51.9) | Buy |
| Bollinger Bands (100): | (38.71 - 48.99) | Buy |
JANX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.15 | Buy |
| Relative Strength Index (14 RSI): | 44.86 | Sell |
| Chaikin Money Flow: | 80974 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.11 - 57.95) | Sell |
| Bollinger Bands (100): | (11.92 - 49.08) | Buy |
FCX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 51.9 | Buy |
| 20-day SMA: | 50.62 | Buy |
| 50-day SMA: | 48.18 | Buy |
| 200-day SMA: | 40.84 | Buy |
| 8-day EMA: | 52.03 | Buy |
| 20-day EMA: | 50.9 | Buy |
| 50-day EMA: | 48.21 | Buy |
| 200-day EMA: | 42.47 | Buy |
JANX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 51.33 | Sell |
| 20-day SMA: | 53.07 | Sell |
| 50-day SMA: | 45.84 | Buy |
| 200-day SMA: | 20 | Buy |
| 8-day EMA: | 50.58 | Sell |
| 20-day EMA: | 51.3 | Sell |
| 50-day EMA: | 44.97 | Buy |
| 200-day EMA: | 26.33 | Buy |
Freeport-McMoRan Earnings Growth & FCX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.06 per share, an increase this year of $0.04 per share, and an increase next year of $0.58 per share.
Janux Therapeutics Earnings Growth & JANX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.05 per share, an increase this year of $0.09 per share, and a decrease next year of $0.57 per share.
Freeport-McMoRan Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Janux Therapeutics Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||